Rani Therapeutics Holdings Inc's Company Valuation
Currency: USD Updated: 2026-07-01
Previous score
6.36
Change
0
The current valuation score of Rani Therapeutics Holdings Inc is 6.36, ranking 332 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.84, which is -84.09% below the recent high of -0.45 and -114.61% above the recent low of -6.10.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.